₹107.88▲2.47%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.76 % |
3 Month Return | + 3.47 % |
1 Year Return | -2.2 % |
Market Stats | |
Previous Close | ₹105.28 |
Open | ₹105.79 |
Volume | 32.09K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹166.64Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹166.64 Cr |
P/B Ratio | 1.02 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹166.64 Cr | 41.84% | 0.69 | NA | NA |
![]() | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
![]() | NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
![]() | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
![]() | NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Organisation | Mangalam Drugs and Organics Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Mangalam Drugs and Organics Ltd
Mangalam Global Enterprise has acquired an Edible Oil Refinery & Packing Unit and an Oil Seed crushing plant, which is expected to enhance its production capabilities. The recent increase in MSP on various Kharif crops may also help boost the company's financials.
Mangalam Industrial Finance Reports Strong Q4 Results - 01 Jun, 2024
Mangalam Industrial Finance reported a YoY revenue growth of 37.13% and reduced its loss by 98.25%. However, QoQ revenue declined by 43.12%, and the company experienced an increase in loss by 160.25%. The SG&A expenses rose by 32.72% QoQ, impacting profitability. The EPS for Q4 showed positive growth of 97.01% YoY. The stock delivered -3.06% return last week but strong returns of 37.62% in the last 6 months and 2.97% YTD.
Retail Holding Up
Retail Investor have increased holdings from 49.42% to 49.47% in Jun 2024 quarter
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 89.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.32% of holdings in Jun 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 171.8%
FII Holding Down
Foreign Institutions have decreased holdings from 0.26% to 0.21% in Jun 2024 quarter
Price Dip
In the last 3 years, MANGALAM stock has moved down by -44.2%
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹359.62Cr | ↑9.26% |
Total Liabilities | ₹207.66Cr | ↑16.28% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹39.52Cr | ↑53.71% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 50.32% | 0.00 | |
Foreign Institutions | 0.21% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 49.47% | 0.10 | |
Others | 0% | 0.00 |
In the quarter ending September 2017, Mangalam Drugs and Organics Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.47%.
Read More about DividendsBearish
Neutral
Bullish
Mangalam Drugs and Organics Ltd is currently in a Bullish trading position according to technical analysis indicators.
Mangalam Drugs and Organics Ltd (MANGALAM) share price today is ₹107.88
Mangalam Drugs and Organics Ltd is listed on NSE
Mangalam Drugs and Organics Ltd is listed on BSE
Today’s traded volume of Mangalam Drugs and Organics Ltd(MANGALAM) is 32.09K.
Today’s market capitalisation of Mangalam Drugs and Organics Ltd(MANGALAM) is ₹166.64Cr.
Mangalam Drugs and Organics Ltd(MANGALAM | Price |
---|---|
52 Week High | ₹132.45 |
52 Week Low | ₹90.8 |
Mangalam Drugs and Organics Ltd(MANGALAM) share price is ₹107.88. It is down -18.55% from its 52 Week High price of ₹132.45
Mangalam Drugs and Organics Ltd(MANGALAM) share price is ₹107.88. It is up 18.81% from its 52 Week Low price of ₹90.8
Mangalam Drugs and Organics Ltd(MANGALAM | Returns |
---|---|
1 Day Returns | 2.6% |
1 Month Returns | -0.76% |
3 Month Returns | 3.47% |
1 Year Returns | -2.2% |